Emmanuel O. Irek, Adewale A. Amupitan, Temitope O. Obadare, Aaron O. Aboderin
1
EngenderHealt;
1
EngenderHealth
1
Erin Berry-Bibee, Melissa Chen, Kathryn Curtis et al.
1
Ewig S.
1
F. O. Fasina, Fasanmi O.G., Makonnen Y. J., et al.
1
Farkas, A.
1
Federal Ministry of Health, Nigeria
1
Fistula Care
1
Flying Publisher, Boehringer Ingelheim
1
Frédéric Kobelembi, F.
1
Frontiers in Chemistry
1
G. Franco-Sotomayor
1
G. Sander
1
García, J.M.
1
GBD 2019 Tuberculosis Collaborators
1
GBD2019 Dementia Forecasting Coolaborators
1
Gentilini U., M. Almenfi, I. Orton
1
Gil, A.
1
Global Alliance for Vaccines and Immunisation (Gavi)
1
Global Clubfoot Initiative (GCI)
1
Global Coalition for Circulatory Health
1
Global Health: Science and Practice
1
Global Task Force for Cholera Control
1
Government of Lesotho
1
Gruber, F.
1
Gulev S. K., Thorne P. W. et al.
1
H. E. Erskine
1
H. Thirumurthy, E. Omanga, B. Obonyo et al.
1
Handicap International
1
Harm Reduction International
1
Hassanein M., Afandi B. et al.
1
Hepatology Society of the Philippines (HSP)
1
Hidalgo, R.
1
Hindawi
1
Hoffmann, C.
1
Human Rights Watch HRW
1
Humanitarian Assistance and Resilience Programme Facility (HARP-F) & Myanmar Information Management Unit (MIMU)
1
I. T. Katz
1
ICF International
1
Indian Consensus of Medical Research
1
Indian Council of Medical Research
1
Informe de la Nutrición Mundial
1
Inter-Agency Standing Committee
1
International Campaign to Ban Landmines – Cluster Munition Coalition (ICBL-CMC)
1
International council of Nurses
1
International Food Policy Research Institute
1
International Pharmaceutical Federation (FIP)
1
International Rescue Committee, et al.
1
J.
1
J. Caldwell
1
J. E. Haberer
1
J. G. Scott
1
J. Gardel Valverde , I. Camara Morais et al.
1
J. M. Nagata
1
Jähnke, R.W.O. and Kornelia Dwornik
1
Jiwanji, A.
1
Journal of Acquired Immune Deficiency Syndromes (JAIDS )
1
JSI Research & Training Institute
1
K. Kulik and U.Binder
1
K. Stone
1
K. vinh quoc Luong, L. T. H. Nquyen
1
Kamali M, Munyuzangabo M, Siddiqui FJ, et al.
1
Kasmera
1
Katie Murphy, Sandra Maignant, Laura Boone, Sarah Smith
1
Kaushik, C.
1
Kerry L.D. MacQuarrie, Lindsay Mallick &
1
Khan, Farzana
1
Khan, J.
1
Kunda J., Gosling S., Foody G. et al.
1
L. Messner, L. Crye
1
L. Napoles
1
L.A. Chimoy and C. Tunoque
1
Langston, A., Weiss, J., Landegger, J., et al.
1
Langwenya, Nontokozo
1
LaRocque, R.
1
Lode, H.
1
Lopez-Bernus, A. et al
1
Lowey, S.E.
1
Lucile Peynot
1
M. Archary
1
M. Gutmann
1
M. Mntonintshi
1
M. Ramos-Ramirez
1
M. Vicari
1
Makanjuola, A. et al.
1
Mapako, Tonderai, Simbarashe Rusakaniko, Maarten J. Postma, Marinus van Hulst, Janet Dzangare, Stellah Ngwende, John Mandisarisa, Ponesai Nyika, David A. Mvere, Owen Mugurungi, and Mufuta Tshimanga
1
Marina Smelyanskaya, John Duncan
1
Mark W. Rosegrant | Jawoo Koo | Nicola Cenacchi
1
Mark, A.
1
Martinez Viciana, C.
1
Maternal & Childhealth Advocacy International (MCAI) , Advanced Life Support Group (ALSG)
1
McGloin, J.
1
MCHIP
1
Md. Akramul Islam, Susumu Wakai, Nobukatsu Ishikawa, A.M.R. Chowdhury, J. Patrick Vaughan
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Médecins Sans Frontières MFS
1
Ministerio de Salud Pública y Bienestar Social Paraguay: et al
1
Ministerio de Salud, Peru
1
Ministère de la Lutte contre le VIH/SIDA, Bangui, RCA
1
Ministère de la Santé Publique et de la Population (M.S.P.P.)
1
Ministry of Public Health, Quatar
1
Monteiro , J.D.
1
Mphande, M.
1
MSMGF
1
Mugomeri, Eltony
1
Mukhtar A Adeiza, Abdullah A Abba, Juliana U Okpapi
1
Munyaneza, F.
1
Mursaleena Islam
1
N. Bam
1
N. K. Arora
1
N. L. Soh
1
N. L. Soh
1
Naciones Unidas Derechos Humanos
1
National Institute of Population Research and Training (NIPORT) and ICF
1
National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International
1
NCBI (National Center for Biotechnology Information)
1
Ndambo, M.K.
1
Nichols, B. E.
1
OCHA
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Oliveira e Souza, R.
1
Ophthalmic Services Unit and the Division of Non Communicable Disease (DNCD), Ministry of Health Kenya
1
Organisation mondiale de la Santé
1
Organisation Mondiale de la Santé (OMS)
1
Organisation mondiale de la Santé (World Health Organization)
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud (Las Americas) (World Health Organization)
1
Organización Mundial de la Salud y Alzheimer’s Disease International
1
Organización Panamericana de la Salud
1
Ortiz-Jiménez
1
Ovid
1
P. Mulongeni
1
Paccaud, F. et al.
1
Pakoyo Fadhiru Kamba, Munanura Edson Ireeta, Sulah Balikuna et al.
1
Pan American Health Organisation PAHO
1
Pan American Health Organization PAHO
1
Paolella, D .A.
1
Pedrozo e Silva de Azevedo, C.
1
PEPFAR
1
Phillips, Tamsin K.
1
PLOS Global Public Health
1
Plos Medicine
1
PLOS One
1
Population Reference Bureau
1
Pub Med
1
Public Health Reviews
1
PubMed.gov
1
Radcliffe
1
Raditladi, Tirelo et al.
1
Republic of Kenya, Ministry of Health
1
Rev Panam de Salud Pública
1
Revista Panamericana de Salud Pública
1
Ricardo Heinzelmann, Rogerio Luz Coelho Neto et al.
1
Rockville, Maryland, USA: ICF International
1
Rodríguez-Muñoz, M. F., Krupelnytska, L. et al.
1
S .Gulati
1
S. Buchan
1
S. Groth, G. Forte et al.
1
S. Hermans
1
S. Ripoll and S. Carter
1
S.B. Calderwood and A.Bloom
1
S.Mabunda
1
Sacks, E.
1
Santos, D.
1
Selby, S.
1
Semmes, Oliver John
1
Sharifa Begum, et al.
1
Sheila Reed, Camille Eric Kouam, Krishna Belbase et al.
1
Shekhar Saxena , Etienne Krug, Oleg Chestnov et al.
1
Sider, R. , Buswell, M. , Al Salman, M. et al.
1
Silva G, Perez F y Marín D
1
Social Science in Humanitarian Action
1
Sociedad Paraguaya de Infectologia (SPI)
1
Sociedade Brasileira de Medicina de Família e Comunidade
1
Societé francaise d'anesthésie et de réanimation (SFAR)
1
SPI
1
Start Network
1
Stefan Mauss, et al.
1
Stephen N. Wong, Jane R. Campos, Ian Homer Y. Cua et al.
1
Stevens, Gretchen
1
Sunita Kishor
1
T. Osman
1
T. Seutloali
1
Tabitha Hrynick, T.
1
Tarun Gera, Dheeraj Shah, Paul Garner et al.
1
Terres des Femmes
1
Tessum, C.
1
The DHS Program
1
The Lancet
1
Thomas Chantereault and Ezzedine Bouzid
1
Ties Boerma, Jennifer Requejo, Cesar Victora et al.
1
Tilahun Tadesse, B., E. A. Ashley, S. Ongarello et al.
1
Torres, A.
1
Tunesian Federation of sport for persons with disabilities
1
UN Children´s Fund
1
UN Children's Fund
1
UN Children's Fund UNICEF
1
UN Office for the Coordination of Humanitarian Affairs
1
UN Relief and Works Agency for Palestine Refugees in the Near East
1
UNHCR (The UN Refugee Agency)
1
United Nations Children's Fund (UNICEF)
1
United Nations Children’s Fund (UNICEF)
1
United Nations Children’s Fund (UNICEF) Evaluation Office
1
United Nations Children’s Fund (UNICEF), World Health Organization (WHO)
1
United Nations Office on Drugs and Crime
1
United Nations Office on Drugs and Crime (UNODC)
1
United Nations Population Fund
1
United States Institute of Peace
1
UNOPS, Stop TB Partnership
1
UpToDate
1
USAID (from the american people)
1
USAID, Health Systems 20
1
USIP
1
Velasco-Tirado, V.
1
Velazquez Berumen, A.
1
Wageningen University and Research Centre
1
Wamai, R.
1
War Child Holland
1
WHO, et al.
1
World
1
World Drug Report 2017
1
World Health Organisation WHO
1
World Health Organitarion
1
World Health Organization (Europe)
1
World Health Organization (WHO) & The World Bank (WB)
1
World Health Organization WHO, PAHO
1
World Health Organization, Imperial College London
1
World Health Organization, TB HIV working group, Stop TB Partnership
1
World Metrological Organisation - WMO
1
World Wildlife Fund for Nature WWF
1
Wounds International
1
Yaria, J.
1
Zaidel, E.J.
1
Ziaggi, G.
1
ВОЗ и Международная организация по проблемам болезни Альцгеймера
More than 700 000 people lose their life to suicide every year. The world is not on track to reach the 2030 suicide reduction targets. WHO advocates for countries to take action to prevent suicide, ideally through a comprehensive national suicide prevention strategy. Governments and communities can ...contribute to suicide prevention by implementing LIVE LIFE – WHO’s approach to starting suicide prevention so that countries can build on it further to develop a comprehensive national suicide prevention strategy. The guide is for all countries, with or without a national suicide prevention strategy; national or local focal points for suicide prevention, mental health, alcohol or NCDs; and community stakeholders with a vested interest or who may already be engaged in implementing suicide prevention activities.
Excecutive Summary available in English, French, Arabic, Chinese, Russian and Spanisch here:more
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...19 e receberam hidroxicloroquina. Três estudos envolveram participantes que tiveram uma exposição conhecida a uma pessoa com infecção por SARS-CoV-2. Em resposta à divulgação dos dados de estudos, o GDG da OMS desenvolveu recomendações sobre a hidroxicloroquina, um agente anti-inflamatório que atua por meio do bloqueio dos receptores Toll-like, reduzindo a ativação das células dendríticas. É usada para tratar a artrite reumatoide e o lúpus eritematoso sistêmico. Tem um efeito antiviral contra muitos vírus in vitro, inclusive o SARS-CoV-2, mas não foi demonstrado um efeito antiviral clinicamente útil para nenhuma infecção viral.more
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...variável, refletindo uma incerteza em grande escala. Numerosos estudos clínicos randomizados de muitos medicamentos estão em andamento para orientar melhor a prática. Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS contém novas
informações e uma recomendação sobre a hidroxicloroquina. (1) Segue-se a publicação de seis estudos sintetizados em uma meta-análise dinâmica de rede (NMA).more
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
... direct-acting antiviral (DAA) treatment of adolescents and children ages ≥3 years of age
simplified HCV service delivery (decentralization, integration and task sharing)
HCV diagnostics – use of point-of-care (POC) HCV ribonucleic acid (RNA) assays and reflex HCV RNA testing.
These guidelines also update existing chapters without new recommendations, such as the inclusion of new manufacturers’ protocols on the use of dried blood spot (DBS) for HCV RNA testing and new data to inform the limit of detection for HCV RNA assays as a test of cure, in addition to their use for diagnosis.more
What are the FP and CAC competencies?
Through the clear articulation of the family planning and comprehensive abortion care (FP and CAC) competencies for the primary health care workforce, the aim is to advance improvements in FP and CAC service delivery by aligning health worker education approach...es with population health needs and health system demands.
This document, which describes these competencies in detail, is intended to:
be a foundational tool to be adopted and adapted by educators and regulators for FP and CAC providers (students) with a pre-service training pathway of at least 12 months;
describe competencies that are relevant to current and future health practice;
enable widespread use of the competencies not only for curriculum development for pre-service education, but also for in-service education, regulation, qualifications, quality assurance, personal development, performance evaluation, recruitment, management and career progression;
focus on the core functions of FP and CAC providers within broader efforts towards achieving universal health coveragemore
Plus de 700 000 personnes perdent la vie par suicide chaque année. La réduction d’un tiers du taux mondial de mortalité par suicide d’ici à 2030 est à la fois un indicateur et une cible (la seule pour la santé mentale) dans les objectifs de développement durable des Nations Unies et dans ...le Plan d’action global de l’OMS pour la santé mentale 2013–2030. Le treizième programme général de travail 2019–2023 de l’OMS comprend le même indicateur avec une réduction de 15 % à l’horizon 2023.
Le monde n’est pas sur la bonne voie pour atteindre les cibles de la réduction du suicide fixées pour 2030. L’OMS encourage les pays à prendre des mesures pour prévenir le suicide, idéalement par le biais d’une stratégie nationale intégrée de prévention du suicide. Les gouvernements et les communautés peuvent contribuer à la prévention du suicide en mettant en œuvre l’approche LIVE LIFE de l’OMS, dont le but est de servir de base pour commencer la prévention du suicide, et dont ils peuvent s’inspirer pour élaborer une stratégie nationale intégrée de prévention du suicide. Le présent guide s’adresse à tous les pays, qu’ils disposent actuellement ou non d’une stratégie nationale de prévention du suicide.more
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ...de personnes à travers le monde étaient atteintes d’une infection chronique par le virus de l’hépatite C, et qu’à peine 21 % d’entre elles avaient été diagnostiquées. Le défaut de sensibilisation, l’accès limité aux services de dépistage et de traitement, la stigmatisation, la discrimination et d’autres obstacles structurels contribuent au faible taux d’utilisation des services de dépistage du virus de l’hépatite C.more
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and comorbidities
which can make severe dehydration harder to tolerate physiologically. With this in mind, a ...scoping review
was undertaken, to explore the literature and summarise the existing evidence on cholera mortality and
reported risk factors.more
Water, sanitation and hygiene education in schools – WASH in Schools – provides safe drinking water, improves sanitation facilities and promotes lifelong health. WASH in Schools enhances the well-being of children and their families, and paves the way for new generations of healthy children.
f...rom Schools offers a snapshot of WASH in Schools experiences across the globe. These stories have been gathered through a retrospective search of UNICEF’s global and country office websites. They represent a myriad of activities undertaken by UNICEF and partners in 2010 and 2011.more
This evaluation is the first systematic effort by UNICEF to generate evidence on how well its global as well as country level Community Management of Acute Malnutrition (CMAM) strategies have worked, including their acceptance and ownership in various contexts and appropriateness of investments in c...apacity development and supply components. Overall, the evaluation recommends that UNICEF continue to promote and support CMAM as a viable approach to preventing and addressing severe acute malnutrition (SAM), with an emphasis on prevention through strengthening community outreach and integrating CMAM into national health systems and with other interventionmore
EVALUATION REPORT | The purpose of the evaluation is to strengthen child protection programming in the context of emergencies by assessing UNICEF’s performance and drawing lessons and recommendations that will influence ongoing and future programmes, in both preparedness and response. Apart from g...lobal and regional interviews and desk reviews, the evaluation is grounded in a solid base of evidence from four indepth case studies of recent emergency responses, in Colombia, Democratic Republic of the Congo, Pakistan and South Sudan, as well as extensive research covering eight additional countries.more
• Clashes continued between the Syrian Democratic Forces (SDF), the Syrian Arab Army (SAA), and Turkish backed forces, concentrated around the M4 highway and Tal Tamer district in Al-Hasakeh. Further displacement was reported.
• Several civilian casualties occurred due to improvised explosive ...devices (IEDs) in Afrin, Quamishli, and along the Tell Abiad-Ras al-Ain corridor. On 16 November, a car bomb in Al Bab, Aleppo reportedly killed 14 people and injured 27, including civilians.
• On 13 November, Alouk water station was repaired following reconnection of the Debarseyah supply line, again restoring water to 460,000 people in Al-Hasakeh city and surrounding areasmore
Every year, an estimated 15 million babies are born preterm – before 37 weeks of pregnancy. That is more than 1 in 10 live births. Approximately 1 million children die each year worldwide due to complications from their early birth. Those that survive often face a lifetime of ill-health including ...disability, learning difficulties, and visual and hearing problems.
Half of the babies born at or below 32 weeks (2 months early) die in low-income settings, due to a lack of feasible, cost-effective care, such as warmth, breastfeeding support, and basic care for infections and breathing difficulties. In high-income countries, almost all these babies survive.more
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra...umatismes accidentels et le paludisme (2). La plupart de ces maladies et de ces problèmes sont, du moins en partie, causés par l'environnement. On a estimé en 2012 que 26 % des décès infantiles et 25 % de la charge totale de morbidité des enfants de moins de cinq ans pourraient être évités par la réduction des risques environnement aux tels que la pollution de l'air, l'insalubrité de l'eau, les mauvaises conditions d'hygiène et d'assainissement ou les produits chimiques.more
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...regarding the use of drugs to treat (rather than prevent) COVID-19 are included in a separate WHO document, Therapeutics and COVID-19: living guideline, that can via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform). Guidelines regarding the clinical management of COVID-19 patients are included in a further document, COVID-19 Clinical management: Living guideline, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).more
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought... together more than 300 people, including 42 Heads of State and Government. 62 countries were represented, notably 14 Gavi implementing countries, all of the G7 nations and 19 governments of the G20. Eminent participants also included H.E. Antonio Guterres, Secretary-General of the United Nations; H.E. Moussa Faki Mahamat, Chairperson of the African Union Commission; H.E. Dr Tedros Adhanom Ghebreyesus, WHO Director-General; H.E. Henrietta Fore, UNICEF Executive Director; Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation; Ministers from implementing and donor countries; CEOs of vaccine manufacturing companies and private sector partners; leaders of UN and other international agencies; senior civil society representatives; and Gavi champions. A full list of the participants can be found in Annex.more
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...nd guidance, and has the following new elements:
It presents an integrated and efficient respiratory pathogen pandemic planning approach covering both novel pathogens and those known to have pandemic potential;
It enables coherence in addressing pathogen-agnostic and pathogen-specific elements for better preparedness;
It gives an organizing framework including operational stages and triggers for escalation and de-escalation between pandemic preparedness and response periods;
It contextualizes 12 IHR (2005) core capacities within the five components of health emergency preparedness, response and resilience (HEPR), from the respiratory threats perspective; and
It describes the critical sectors for respiratory pathogen pandemic preparedness to trigger multisectoral collaboration.
WHO will finalize and publish this Module after a global technical meeting that will be held on 24-26 April 2023.more